The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo

Yifang Li,Alex Hunter,Miqdad M. Wakeel,Guizhi Sun,Ricky W. K. Lau,Brad R. S. Broughton,Ivan E. Oyarce Pino,Zihao Deng,Tingfang Zhang,Padma Murthi,Mark P. Del Borgo,Robert E. Widdop,Jose M. Polo,Sharon D. Ricardo,Chrishan S. Samuel
DOI: https://doi.org/10.1186/s13287-024-03992-x
2024-10-26
Stem Cell Research & Therapy
Abstract:Kidney fibrosis is a hallmark of chronic kidney disease (CKD) and compromises the viability of transplanted human bone marrow-derived mesenchymal stromal cells (BM-MSCs). Hence, BM-MSCs were genetically-engineered to express the anti-fibrotic and renoprotective hormone, human relaxin-2 (RLX) and green fluorescent protein (BM-MSCs-eRLX + GFP), which enabled BM-MSCs-eRLX + GFP delivery via a single intravenous injection.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?